help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on February 11, 2005, doi:10.1164/rccm.200411-1603OE

Am. J. Respir. Crit. Care Med., Volume 171, Number 7, April 2005, 699-706

A more recent version of this article appeared on April 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200411-1603OEv1
171/7/699    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitchison, D. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitchison, D. A

Submitted on November 30, 2004
Accepted on January 19, 2005

The Diagnosis and Therapy of Tuberculosis During the past 100 Years

Denis A Mitchison1*

1 Medical Microbiology, Department of Cellular and Molecular Medicine, St. George's Hospital Medical School, London, United Kingdom

* To whom correspondence should be addressed. E-mail: dmitchis{at}sghms.ac.uk.

Methods for the radiographic diagnosis of tuberculosis have improved from simple fluoroscopy to computerised tomography. While direct smear examination is still the most widely used bacteriological method of diagnosis, cultural methods with selective liquid media are sensitive and rapid. The use of anti-tuberculosis drugs has changed tuberculosis from a disease with about a 50% mortality, treated by measures to collapse the affected lung lesions and by rest for the patient, to a condition successfully curable by chemotherapy. Key steps in the development of modern chemotherapy regimens were the demonstrations in clinical trials that [1] streptomycin was effective; [2] combination of drugs prevented the emergence of drug-resistant Mycobacterium tuberculosis; [3] chemotherapy under domiciliary conditions was effective and did not put family members at risk of infection; [4] patient compliance could be assisted by fully supervised intermittent regimens, or more effectively, by [5] shortening treatment by the introduction of rifampin and pyrazinamide, the two most potent sterilizing drugs, into the regimens. Regimens were divided into an initial intensive phase while bacterial populations were high and a longer continuation phase to complete sterilization. Pyrazinamide was shown to sterilize only in the intensive phase. The treatment of non-pulmonary tuberculosis followed the same plan but when bacterial populations are low, fewer drugs are required in combination.


Key words: Tuberculosis, treatment, diagnosis




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
R. J. Wilkinson and C. Lange
Vitamin D and Tuberculosis: New Light on a Potent Biologic Therapy?
Am. J. Respir. Crit. Care Med., May 1, 2009; 179(9): 740 - 742.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. C. Leung and W. W. Yew
Does Current Drug Resistance Surveillance Provide Useful Information in Tuberculosis?
Am. J. Respir. Crit. Care Med., January 1, 2009; 179(1): 82 - 82.
[Full Text] [PDF]


Home page
Ther Adv Respir DisHome page
E. S. Guy and A. Mallampalli
Review: Managing TB in the 21st century: existing and novel drug therapies
Therapeutic Advances in Respiratory Disease, December 1, 2008; 2(6): 401 - 408.
[Abstract] [PDF]


Home page
BMJHome page
A. Grant, P. Gothard, and G. Thwaites
Managing drug resistant tuberculosis
BMJ, August 28, 2008; 337(aug28_1): a1110 - a1110.
[Full Text]


Home page
ChestHome page
M. H. Baumann, R. Nolan, M. Petrini, Y. C. G. Lee, R. W. Light, and E. Schneider
Pleural Tuberculosis in the United States: Incidence and Drug Resistance
Chest, April 1, 2007; 131(4): 1125 - 1132.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. Ewer, K. A. Millington, J. J. Deeks, L. Alvarez, G. Bryant, and A. Lalvani
Dynamic Antigen-specific T-Cell Responses after Point-Source Exposure to Mycobacterium tuberculosis
Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 831 - 839.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. W. Yew and C. C. Leung
Prognostic significance of early weight gain in underweight patients with tuberculosis.
Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 236 - 237.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
B. J. Marais, R. P. Gie, H. S. Schaaf, N. Beyers, P. R. Donald, and J. R. Starke
Childhood Pulmonary Tuberculosis: Old Wisdom and New Challenges
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1078 - 1090.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society
  New Orleans Int'l Conf